5 August 2020
The discovery of an aberrantly expressed gene by a team of MRC WIMM researchers could lead to curative treatments for currently incurable childhood leukemias.
5 August 2020
Researchers from the MRC-Human Immunology Unit, supported by the NIHR Oxford Biomedical Research Centre, have used an ‘atlas’ of immune cells in the human colon to find evidence of the role of CD8 T cells in inflammatory bowel disease. The findings could pave the way for more targeted treatments for this chronic disorder.
22 July 2020
Researchers at the MRC Weatherall Institute of Molecular Medicine have recently discovered why a class of cancer drugs is beneficial only in a subset of patients. The results could pave the way for the future development of these drugs, known as PNP-inhibitors, as personalised medicines.
16 July 2020
Analyses of samples from the MRC WIMM archives conducted by Stanford Medicine researchers and collaborators have settled a long-brewing controversy about whether ancient Polynesians and Native Americans had contact.
6 July 2020
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.
19 June 2020
A machine learning tool to characterise complex 4D image tissue and organism data could aid research into diseases such as neurodegenerative disorders and cancer.
12 June 2020
A new study led by Radcliffe Department of Medicine researchers analyses iron levels in COVID-19 intensive care patients to find that patients with very low levels of iron had severe respiratory failure.
9 June 2020
The study builds on a successful collaboration and will compare T cell and antibody responses to uncover the role of ‘background’ immunity to virus strains already in circulation, including infections with similar coronaviruses.
2 June 2020
Associate Professor Ross Chapman joins us along with his research group from the 1st of June 2020.
29 May 2020
The Ahmed lab and collaborators develop new sequencing approach to uncover active mutational processes in cancer and pre-cancer conditions.
27 May 2020
New findings by a team of MRC WIMM researchers could help us harness immune system cells by enhancing antigen-specific responses.
26 May 2020
The collaboration has led to the first pre-clinical model of acute erythroid leukaemia.
14 May 2020
The study, led by Dr Beth Psaila, identifies a new approach for targeting cancer-driven cells.